Economic Evaluation of Omalizumab Compared With Standard Therapy in the Treatment of Severe Allergic Asthma in Adult Patients in Greece: a Cost Effectiveness Analysis Based on Clinical Trial and Real-World Data.

Sonathi, V; Hatzikou, M; Baldwin, M; Panitti, E; Tzortzaki, E

Sonathi, V; Hatzikou, M; Baldwin, M; Panitti, E; Tzortzaki, E.

Afiliação

Sonathi V; Novartis Healthcare Pvt. Ltd., Hyderabad, India.
Hatzikou M; Novartis Hellas, Metamorfosis, Greece.
Baldwin M; Novartis Employee by the time of the study, Horsham, UK.
Panitti E; Novartis Hellas, Metamorfosis, Greece.
Tzortzaki E; Medical School University of Crete, Heraklion, Greece.

Value Health ; 17(7): A597-8, 2014 Nov.

Article em En | MEDLINE | ID: mdl-27202057

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Revista: Value Health Assunto da revista: FARMACOLOGIA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google